OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

2 Projects | 2 Researchers | $493,090 Invested

2025

Beth Israel Deaconess Medical Center

Chenxi Qiu, PhD

A new therapeutic antibody for Frontotemporal Dementia

  • Funding Amount: $349,590
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Active

2011

Beth Israel Deaconess Medical Center

Kun Ping Lu, MD, PhD

Development and Efficacy Evaluation of Novel Immunotherapy for Human Tauopathies

  • Funding Amount: $143,500
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed